As we have mentioned, being increased in the CD4+ and CD8+ subtypes in peripheral blood of patients with hepatocellular carcinoma, the p-STAT3 expression can lead to aberrant immunological surveillance, thus promoting the development of hepatocellular carcinoma [17]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.